Dr. Chang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1500 East Medical Ctr Dr
B1 Floor Cancer & Geriatrics Ctr Recp E
Ann Arbor, MI 48109Phone+1 734-647-8902- Is this information wrong?
Education & Training
- University of Pennsylvania Health SystemResidency, Surgery, 1979 - 1982
- Duke University HospitalResidency, Surgery, 1974 - 1976
- Harvard Medical SchoolClass of 1974
Certifications & Licensure
- MI State Medical License 1987 - 2025
- PA State Medical License 1979 - 1998
- MD State Medical License 1977 - 1984
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2003-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Publications & Presentations
PubMed
- The Effect of Wire Versus Magnetic Seed Localization on Lumpectomy Cavity Size.Aldous, J., Jiang, S., Schipper, M., Dykstra, M., Thompson, J., Hughes, T., Hayman, J., Dragovic, A., Shah, J., Chang, A., Speers, C., Sabel, M., Dossett, L., Jagsi, R.> ;Practical Radiation Oncology. 2023 Dec 30
- 4 citationsCancer stem cell antigen nanodisc cocktail elicits anti-tumor immune responses in melanoma.Marisa E Aikins, You Qin, Hannah E Dobson, Alireza Hassani Najafabadi, Kexing Lyu, Yao Xu, Ying Xin, Anna Schwendeman, Max S Wicha, Alfred E Chang, Qiao Li, James J Moon> ;Journal of Controlled Release. 2022 Nov 1
- 2 citationsProphylactic mastectomy and occult malignancy: Surgical and imaging considerations.Jessica L Thompson, Brandy R Sinco, Rachel L McCaffrey, Alfred E Chang, Michael S Sabel, Lesly A Dossett, Tasha M Hughes, Jacqueline S Jeruss> ;Journal of Surgical Oncology. 2023 Jan 1
- Join now to see all
Press Mentions
- Immunotherapy for Solid MalignanciesApril 21st, 2019
Grant Support
- University Of Michigan Surgical Oncology Research Training ProgramNational Cancer Institute2006–2011
- Immunological MonitoringNational Cancer Institute2006–2010
- T And B Cell Activation Of Cancer ImmunotherapyNational Cancer Institute2009
- T Cell Activation For Cancer ImmunotherapyNational Cancer Institute1999–2008
- T Cell Therapy Of Human Renal Cell CancerNational Cancer Institute1996–2007
- Research Training In Translational Tumor ImmunologyNational Cancer Institute2005
- Surgical Oncology Research Training ProgramNational Cancer Institute2004–2005
- Cellular Vaccines For Cancer TherapyNational Cancer Institute2004–2005
- Pilot--Gastrointestinal OncologyNational Cancer Institute2001–2002
- Immune Responses Induced By Tumor-Pulsed Dendritic CellsNational Cancer Institute2001–2002
- Core--ImmunologyNational Cancer Institute2001–2002
- Core--Immunologic MonitoringNational Cancer Institute2001–2002
- Core--CoordinationNational Cancer Institute2001–2002
- Immunotherapy Of Melanoma With Lymph Node Primed With Gmcsf Gene Transduced CellNational Center For Research Resources1998–2002
- Dendritic Cells Activated By Gmcsf &Il4 As A Tumor Vaccine In Advanced CancerNational Center For Research Resources1998–2002
- Immunotherapy Of Malignacy By In Vivo Gene Transfer Into TumorsNational Center For Research Resources1997–2002
- Cellular Therapy Of Cancer With Tumor Primed Anti CD3 Activated LymphocytesNational Center For Research Resources1996–2002
- Immune Responses Induced By Gene TransferNational Cancer Institute1997–2000
- Genetic Approaches For Cancer ImmunotherapyNational Cancer Institute1992–2000
- Surgical Oncology Training In Tumor ImmunologyNational Cancer Institute1991–2000
- Immunotherapy Of Melanoma With Activated Lymph Node Cells Primed In VivoNational Center For Research Resources1997
- IUDR And Radiation Therapy In Treatment Of Head And Neck SarcomasNational Center For Research Resources1996
- Immunotherapy Of Melanoma Cells Primed In Vivo With Tumor Cells With IL4National Center For Research Resources1996
- Adoptive Immunotherapy Utilizing T Cells Induced By Gene Modified Human CancersNational Cancer Institute1996
- Immune Responses To Genetically Modified TumorsNational Cancer Institute1992–1993
- Adoptive Therapy Of Human Cancer With Sensitized T CellsNational Cancer Institute1990–1992
Professional Memberships
- Member
Hospital Affiliations
- University of Michigan Medical CenterAnn Arbor, Michigan
- Veterans Affairs Ann Arbor Healthcare SystemAnn Arbor, Michigan
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: